化工社化工社 化学情報印刷レポート · 研究参考用
4-Methylmorpholine → 6-[(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)carbonyl]-N-(4-pyridinylmethyl)-2-pyridinecarboxamide, hydrochloride
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | 4-Methylmorpholine | HCID 7972 | — |
| 反応物 | 4-Pyridinemethanamine | HCID 77317 | — |
| 反応物 | 2,6-Pyridinedicarbonyl dichloride | HCID 77335 | — |
| 反応物 | 8-Chloro-dibenz[b,f]-[1,4]oxazepine | HCID 838267 | — |
| 溶媒 | Chloroform | HCID 6212 | — |
| 生成物 | 6-[(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)carbonyl]-N-(4-pyridinylmethyl)-2-pyridinecarboxamide, hydrochloride | HCID 131719014 | — |
反応手順
A solution of 8-chloro-dibenz[b,f][1,4]oxazepine (0.77 g), 2,6-pyridine-dicarbonyl chloride (0.68 g) and 4-methylmorpholine (0.367 mL) in CHCl3 (33 mL) was allowed to stand at ambient temperature for 16 hours. To this solution was added 4-(aminomethyl)pyridine (0.34 mL) and the mixture was allowed to stand at ambient temperature for 16 hours. The mixture was concentrated and the residue was extracted with ethyl acetate and saturated NaHCO3. The organic extract was concentrated and the residue chromatographed over silica gel using 50% ethyl acetate in hexane. Appropriate fractions were pooled and concentrated to give the free base of the title compound as a white solid. The HCl salt of the free base was made as described in Example 3.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US05420270 |
| 出典データセット | uspto-grants-1995_05 |
| ORD ID | ord-f8ddeab8d46441a4b8fa8589c29649fd |
| 出典メモ | uspto-grants-1995_05 |